Can a disrupted cortisol rhythm reduce T4 to active T3 conversion?

The interaction between the hypothalamic-pituitary-adrenal (HPA) axis and the thyroid system represents a vital homeostatic link. Disrupted cortisol secretion directly impairs the body's ability to activate thyroid hormones at the tissue level, establishing a state of localized hypothyroidism even when standard thyroid markers appear normal.

Mechanistic pathway of deiodinase alteration

• Downregulation of activating enzymes: Elevated or dysregulated cortisol levels act via genomic pathways to suppress the transcription and activity of type 1 (D1) and type 2 (D2) deiodinases, the enzymes responsible for converting inactive thyroxine ($T_4$) to active triiodothyronine ($T_3$).
• Upregulation of inactivating enzymes: Concurrently, cortisol upregulates type 3 deiodinase (D3) activity. D3 catalyzes inner-ring deiodination, diverting $T_4$ into inactive reverse $T_3$ ($rT_3$) and accelerating the clearance of active $T_3$.

Systemic endocrine impact

• Altered thyroid hormone ratios: This coordinated enzymatic shift decreases the circulating $T_3$:$T_4$ ratio while significantly elevating the $rT_3$:$T_4$ ratio, leading to tissue-level thyroid hormone deficiency.
• Central axis suppression: Beyond peripheral conversion, sustained cortisol elevation blunts thyrotropin-releasing hormone (TRH) and thyroid-stimulating hormone (TSH) secretion, flattening the normal nocturnal TSH surge.

Bottom line

• Disrupted cortisol rhythms systematically impair thyroid function by downregulating D1/D2 and upregulating D3. This reduces peripheral $T_4$-to-$T_3$ conversion, drives inactive $rT_3$ production, and blunts TSH secretion, leading to functional tissue-level hypothyroidism that may elude standard TSH screening.